Skip to main content
OpenTrials

Clinical trial condition

Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma

Explore clinical trials studying Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma trial results

Completed

Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer

NCT02898207

Conditions
Breast Diseases, Breast Neoplasms, Metastatic High Grade Fallopian Tube Serous Adenocarcinoma, +27 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

NCT04739800

Conditions
Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma, +47 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 392 locations
View Trial Details

Related conditions